$0.00
(0.47%)
Add to watchlist
Create an alert
Stocks and Shares ISAMaxCyte, Inc. is a commercial cell engineering company. The Company is focused on providing enabling platform technologies to advance the discovery, development and commercialization of cell therapeutics, including cell and gene therapies, and to support cell-based research and development. It has developed and commercialized its proprietary Flow Electroporation technology, which is used by biopharmaceutical companies in the complex engineering of a variety of cells. Its ExPERT platform is based on its Flow Electroporation technology, which has been designed to address this rapidly expanding cell therapy market and can be utilized across the continuum of the cell therapy sector, from discovery and development through commercialization of cell-based medicines. The ExPERT family of products includes four instruments, which are known as the ATx, STx, GTx and VLx, as well as a portfolio of proprietary related disposables and consumables.
Company Information
About this company
Key people
Maher Masoud
President, Chief Executive Officer, Director
David Sandoval
Senior Vice President, General Counsel, Corporate Secretary
Richard H. Douglas
Non-Executive Independent Chairman of the Board
Yasir B. Al-Wakeel
Non-Executive Independent Director
Patrick J. Balthrop
Non-Executive Independent Director
William W. Brooke
Non-Executive Independent Director
Cynthia L. Collins
Non-Executive Independent Director
Click to see more
Key facts
- Shares in issue106.67m
- EPICMXCT
- ISINUS57777K1060
- LocationUnited States
- SectorHealthcare
- IndustryMedical Equipment & Supplies
- Market cap$92.81m
- Employees114
- ExchangeNASDAQ
- Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.